Interpace Biosciences Inc logo

Interpace Biosciences Inc

OTCPK:IDXG (USA)  
$ 1.56 -0.045 (-2.81%) 11:09 PM EST
At Loss
Enterprise V:
$ 15.42M
Volume:
107.00
Avg Vol (2M):
6.75K
Also Trade In:
Volume:
107.00
At Loss
Avg Vol (2M):
6.75K

Business Description

Description
Interpace Biosciences Inc is engaged in the life sciences industry. It provides molecular diagnostics, bioinformatics, and pathology services for the evaluation of the risk of cancer by leveraging the latest technology in personalized medicine for improved patient diagnosis and management. The company develops and commercializes genomic tests and related first-line assays principally focused on the early detection of patients with indeterminate biopsies and at high risk of cancer using the latest technology. It operates under one segment which is the business of developing and selling diagnostic clinical services.
Name Current Vs Industry Vs History
Cash-To-Debt 0.37
Equity-to-Asset -4.4
Debt-to-Equity -0.22
Debt-to-EBITDA 14.7
Interest Coverage 0.83
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -22.4
Distress
Grey
Safe
Beneish M-Score -2.98
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.93
Quick Ratio 0.84
Cash Ratio 0.41
Days Inventory 29.14
Days Sales Outstanding 48.63
Days Payable 35.07

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.1
Shareholder Yield % -21.21

Financials

IDXG's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:IDXG

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Interpace Biosciences Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 37.373
EPS (TTM) ($) -3.6
Beta 1.03
Volatility % 211.2
14-Day RSI 59.32
14-Day ATR ($) 0.080146
20-Day SMA ($) 1.4859
12-1 Month Momentum % -1.87
52-Week Range ($) 0.6203 - 3.54
Shares Outstanding (Mil) 4.32

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Interpace Biosciences Inc Filings

Filing Date Document Date Form
No Filing Data

Interpace Biosciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Interpace Biosciences Inc Frequently Asked Questions

What is Interpace Biosciences Inc(IDXG)'s stock price today?
The current price of IDXG is $1.56. The 52 week high of IDXG is $3.54 and 52 week low is $0.62.
When is next earnings date of Interpace Biosciences Inc(IDXG)?
The next earnings date of Interpace Biosciences Inc(IDXG) is .
Does Interpace Biosciences Inc(IDXG) pay dividends? If so, how much?
Interpace Biosciences Inc(IDXG) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1